Hervé Avet‐Loiseau

Centre Hospitalier Universitaire de Toulouse

Also affiliated with Centre de Recherches en Cancérologie de Toulouse, Institut universitaire du cancer de Toulouse Oncopole

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma”.

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

New England Journal of Medicine(2022)10.1056/nejmoa2204925

N/A

6.2DataRank · unranked

474 citations

Susanna Jacobus, Edie Weller, Hani Hassoun, Sagar Lonial, Noopur Raje +51 more

A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma

Blood Advances(2020)10.1182/bloodadvances.2020002827

N/A

0DataRank · unranked

416 citations

Hervé Avet‐Loiseau, Kenneth C. Anderson, Paola Neri, Bruno Paiva, Mehmet Samur +11 more

Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma

Nature Communications(2021)10.1038/s41467-021-21177-5

N/A

0DataRank · unranked

414 citations

Mariateresa Fulciniti, Anıl Aktaş Samur, Abdul Hamid Bazarbachi, Yu‐Tzu Tai, Rao Prabhala +10 more

Improved survival in multiple myeloma during the 2005–2009 and 2010–2014 periods

Leukemia(2021)10.1038/s41375-021-01250-0

N/A

0DataRank · unranked

41 citations

Aurore Perrot, Cyrille Hulin, Denis Caillot, Anne‐Marie Stoppa, Thierry Façon +25 more

IgM-MM is predominantly a pre–germinal center disorder and has a distinct genomic and transcriptomic signature from WM

Blood(2021)10.1182/blood.2021011452

N/A

0DataRank · unranked

21 citations

Hervé Avet‐Loiseau, Raphaël Szalat, Anıl Aktaş Samur, Zachary R. Hunter, Masood A. Shammas +9 more

Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor

Blood(2022)10.1182/blood.2022017863

N/A

0DataRank · unranked

63 citations

Alexis Talbot, Aurore Perrot, Titouan Cazaubiel, Xavier Leleu, Salomon Manier +22 more

In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations

Journal of Clinical Oncology(2022)10.1200/jco.21.01987

N/A

0DataRank · unranked

45 citations

Mehmet Samur, Aurore Perrot, Céline Mazzotti, Marion Divoux, Titouan Cazaubiel +17 more

Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features

Blood(2022)10.1182/blood.2021014968

N/A

0DataRank · unranked

29 citations

Xavier Leleu, Aurore Perrot, Salomon Manier, Laure Buisson, Sabrina Mahéo +22 more

In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors

Blood Cancer Journal(2022)10.1038/s41408-022-00759-6

N/A

0DataRank · unranked

25 citations

Mariateresa Fulciniti, Hervé Avet‐Loiseau, Michael Lopez, Sanika Derebail, Jill Corre +8 more

TCR-independent CD137 (4-1BB) signaling promotes CD8+-exhausted T cell proliferation and terminal differentiation

Immunity(2023)10.1016/j.immuni.2023.06.007

N/A

0DataRank · unranked

115 citations

Nadège Carrié, Marine Cuisinier, Samira Ghazali, Allison Voisin, Pierre‐Paul Axisa +21 more

High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma

Blood(2023)10.1182/blood.2022017094

N/A

0DataRank · unranked

48 citations

Marco Roncador, Anıl Aktaş Samur, Mariateresa Fulciniti, Abdul Hamid Bazarbachi, Raphaël Szalat +14 more

Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions

Blood Cancer Journal(2023)10.1038/s41408-023-00933-4

N/A

0DataRank · unranked

27 citations

Aurore Perrot, Titouan Cazaubiel, Xavier Leleu, Lydia Montes, Caroline Jacquet +19 more

Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival

Frontiers in Oncology(2023)10.3389/fonc.2023.1271807

N/A

0DataRank · unranked

10 citations

William E. Pierceall, Mehmet Samur, Lakshmi B. Potluri, Kevin Hong, Teresa Peluso +18 more

Investigation into aberrant B cell repertoire in myeloma on humoral immunity and patient survival.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.8016

N/A

0DataRank · unranked

2 citations

Hannah Seah, Vaishnavi Reddy Bade, Arthur Krogman, Shree Acharya, Andreea Negroiu +13 more

Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes

Nature Communications(2024)10.1038/s41467-024-47793-5

N/A

0DataRank · unranked

24 citations

Raphaël Szalat, Srikanth Talluri, Mariateresa Fulciniti, Hervé Avet‐Loiseau, Giovanni Parmigiani +3 more

Timing the initiation of multiple myeloma

Nature Communications(2020)10.1038/s41467-020-15740-9

N/A

0DataRank · unranked

165 citations

Venkata D. Yellapantula, Daniel Leongamornlert, Niccolò Bolli, Guy Ledergor, Ferran Nadeu +21 more

International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

Journal of Clinical Oncology(2025)10.1200/jco-24-01893

N/A

0DataRank · unranked

142 citations

Faith E. Davies, Mehmet Samur, Jill Corre, Mattia D’Agostino, Martin Kaiser +41 more